Oxford BioMedica PLC (LSE:OXB) - Share price


Stock Report

Oxford BioMedica PLC OXB

Last Price
GBX708.00

Day Change
1.00|0.14%

As of 26/06/2019
16:57:19 BST | GBX
Minimum 15 Minutes Delay.

Last Close707.00p
Day Range703.00 - 737.14
Mkt Cap542.50Mil
52-Wk Range581.00 - 1,029.40
Yield %-
ISINGB00BDFBVT43
Volume43,124
P/E181.96
P/S0.07
P/CF0.38

Share Price

Total Returns 25/06/2019

 Chg (%)  
More ...
Oxford BioMedica PLC2.46 
FTSE 100 TR GBP2.26
 
Financials
201620172018
More ...
Income Statement
Turnover27.7837.5966.78
Operating Profit-11.31-7.977.93
Net Profit-16.64-9.027.54
Reported EPS-30.00-14.5010.89
Balance Sheet
Current Assets27.4436.9869.53
Non Current Assets29.5028.4242.87
Total Assets56.9465.40112.40
Current Liabilities9.3221.7628.51
Total Liabilities---
Total Equity12.626.1534.74
Cash Flow
Operating Cash Flow-5.93-1.539.21
Net Change in Cash5.98-1.0117.92

Regulatory News

DateAuthor Headline
10/08/2018Emma Simon Investor Views: Will Rolls Royce Shares Deliver an Early Retirement?
Private investor Jon Batley is building a share portfolio which he hopes will allow him to retire early
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
23/05/2019PurchaseDr. Lorenzo Tallarigo,M.D.689.503882,675.00
25/04/2019PurchaseDr. Lorenzo Tallarigo,M.D.705.503792,674.00
23/04/2019PurchaseDr. Andrew John William Heath668.002,71118,109.00
23/04/2019PurchaseDr. Andrew John William Heath673.003,31222,290.00

Company Profile

Oxford BioMedica PLC is a biopharmaceutical company based in the United Kingdom. It develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

Sector

Biotechnology

Index

FTSE SmallCap ,FTSE All Share ,FTSE techMARK Focus ,FTSE techMARK All Share

Next Event 13/09/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)68.32
Div Yld (E)0.00
PEG (E)0.00
ROCE13.39
Op Mrgn0.12
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr John Dawson
Non-Executive Director, Deputy ChairmanDr. Andrew John William Heath
Non-Executive DirectorMr. Martin Henry Diggle
Non-Executive DirectorMr. Stuart Henderson
Executive Director, Chief Financial OfficerStuart Paynter
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.